231 related articles for article (PubMed ID: 7867610)
1. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.
Gnudi L; Tozzo E; Shepherd PR; Bliss JL; Kahn BB
Endocrinology; 1995 Mar; 136(3):995-1002. PubMed ID: 7867610
[TBL] [Abstract][Full Text] [Related]
2. High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (Glut 4) in fat cells of rats.
Pedersen O; Kahn CR; Flier JS; Kahn BB
Endocrinology; 1991 Aug; 129(2):771-7. PubMed ID: 1855475
[TBL] [Abstract][Full Text] [Related]
3. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).
Gibbs EM; Stock JL; McCoid SC; Stukenbrok HA; Pessin JE; Stevenson RW; Milici AJ; McNeish JD
J Clin Invest; 1995 Apr; 95(4):1512-8. PubMed ID: 7706456
[TBL] [Abstract][Full Text] [Related]
4. High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice.
Ikemoto S; Thompson KS; Takahashi M; Itakura H; Lane MD; Ezaki O
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3096-9. PubMed ID: 7724522
[TBL] [Abstract][Full Text] [Related]
5. Transgenic GLUT-4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis.
Tozzo E; Shepherd PR; Gnudi L; Kahn BB
Am J Physiol; 1995 May; 268(5 Pt 1):E956-64. PubMed ID: 7762651
[TBL] [Abstract][Full Text] [Related]
6. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA
Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
[TBL] [Abstract][Full Text] [Related]
7. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.
Hamann A; Benecke H; Le Marchand-Brustel Y; Susulic VS; Lowell BB; Flier JS
Diabetes; 1995 Nov; 44(11):1266-73. PubMed ID: 7589822
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter.
Hansen PA; Gulve EA; Marshall BA; Gao J; Pessin JE; Holloszy JO; Mueckler M
J Biol Chem; 1995 Jan; 270(4):1679-84. PubMed ID: 7829503
[TBL] [Abstract][Full Text] [Related]
9. Expression of an insulin-responsive glucose transporter (GLUT4) minigene in transgenic mice: effect of exercise and role in glucose homeostasis.
Ikemoto S; Thompson KS; Itakura H; Lane MD; Ezaki O
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):865-9. PubMed ID: 7846068
[TBL] [Abstract][Full Text] [Related]
10. The effects of insulin on the level and activity of the GLUT4 present in human adipose cells.
Kozka IJ; Clark AE; Reckless JP; Cushman SW; Gould GW; Holman GD
Diabetologia; 1995 Jun; 38(6):661-6. PubMed ID: 7672486
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice.
Ren JM; Marshall BA; Mueckler MM; McCaleb M; Amatruda JM; Shulman GI
J Clin Invest; 1995 Jan; 95(1):429-32. PubMed ID: 7814644
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice.
Liu ML; Olson AL; Moye-Rowley WS; Buse JB; Bell GI; Pessin JE
J Biol Chem; 1992 Jun; 267(17):11673-6. PubMed ID: 1601840
[TBL] [Abstract][Full Text] [Related]
13. Comparison of glucose-transporter-containing vesicles from rat fat and muscle tissues: evidence for a unique endosomal compartment.
Kandror KV; Coderre L; Pushkin AV; Pilch PF
Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):383-90. PubMed ID: 7733873
[TBL] [Abstract][Full Text] [Related]
14. Effect of in vivo thyroid hormone status on insulin signalling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes.
Matthaei S; Trost B; Hamann A; Kausch C; Benecke H; Greten H; Höppner W; Klein HH
J Endocrinol; 1995 Feb; 144(2):347-57. PubMed ID: 7706987
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte traits limiting cellular insulin responsiveness and glucose transport.
Fryklund C; Neuhaus M; Stenkula KG
Am J Physiol Endocrinol Metab; 2023 Dec; 325(6):E682-E687. PubMed ID: 37877798
[TBL] [Abstract][Full Text] [Related]
16. Glucose transporters: structure, function, and regulation.
Assimacopoulos-Jeannet F; Cusin I; Greco-Perotto RM; Terrettaz J; Rohner-Jeanrenaud F; Zarjevski N; Jeanrenaud B
Biochimie; 1991 Jan; 73(1):67-70. PubMed ID: 2031959
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: a longitudinal study.
Vestergaard H; Weinreb JE; Rosen AS; Bjørbaek C; Hansen L; Pedersen O; Kahn BB
J Clin Endocrinol Metab; 1995 Jan; 80(1):270-5. PubMed ID: 7829624
[TBL] [Abstract][Full Text] [Related]
18. GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization.
Burcelin R; Crivelli V; Perrin C; Da Costa A; Mu J; Kahn BB; Birnbaum MJ; Kahn CR; Vollenweider P; Thorens B
J Clin Invest; 2003 May; 111(10):1555-62. PubMed ID: 12750405
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone-induced changes in glucose transporter 4 in rat heart muscle, skeletal muscle and adipocytes.
Oda N; Nakai A; Mokuno T; Sawai Y; Nishida Y; Mano T; Asano K; Itoh Y; Kotake M; Kato S
Eur J Endocrinol; 1995 Jul; 133(1):121-6. PubMed ID: 7627333
[TBL] [Abstract][Full Text] [Related]
20. Effect of a beta-adrenergic agonist on glucose transport and insulin-responsive glucose transporters (GLUT4) in brown adipose tissue of control and obese fa/fa rats.
Assimacopoulos-Jeannet F; Greco-Perotto R; Terrettaz J; Meier MK; Jeanrenaud B
Pflugers Arch; 1992 May; 421(1):52-8. PubMed ID: 1352872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
